Additionally, in a study involving women with polycystic ovary syndrome (PCOS), it has been discussed that the increased risk of endometrial hyperplasia and malignancy in PCOS may be linked to decreased CASP3 (Caspase-3) activity in these patients28. This evidence concerns the gene CASP3 and polycystic ovary syndrome.